• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性骨髓增殖性疾病患者的内皮祖细胞缺乏疾病特异性分子克隆性标志物。

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker.

作者信息

Piaggio Giovanna, Rosti Vittorio, Corselli Mirko, Bertolotti Francesca, Bergamaschi Gaetano, Pozzi Sarah, Imperiale Davide, Chiavarina Barbara, Bonetti Elisa, Novara Francesca, Sessarego Mario, Villani Laura, Garuti Anna, Massa Margherita, Ghio Riccardo, Campanelli Rita, Bacigalupo Andrea, Pecci Alessandro, Viarengo Gianluca, Zuffardi Orsetta, Frassoni Francesco, Barosi Giovanni

机构信息

Divisione Ematologia, Ospedale San Martino, Genova.

出版信息

Blood. 2009 Oct 1;114(14):3127-30. doi: 10.1182/blood-2008-12-190991. Epub 2009 Jul 23.

DOI:10.1182/blood-2008-12-190991
PMID:19628707
Abstract

Two putative types of circulating endothelial progenitor cells have been recently identified in vitro: (1) endothelial colony-forming cell (ECFC) and (2) colony-forming unit-endothelial cell (CFU-EC). Only the former is now recognized to belong to endothelial lineage. We have used the ECFC and CFU-EC assays to readdress the issue of the clonal relation between endothelial progenitor cells and hematopoietic stem cells in patients with Philadelphia-positive and Philadelphia-negative chronic myeloproliferative disorders. Both ECFCs and CFU-ECs were cultured from peripheral blood mononuclear cells, and either BCR-ABL rearrangement or JAK2-V617F mutation were assessed in both types of endothelial colonies. We found that ECFCs lack the disease-specific markers, which are otherwise present in CFU-ECs, thus reinforcing the concept that the latter belongs to the hematopoietic lineage, and showing that in chronic myeloproliferative disorders the cell that gives rise to circulating ECFC has a distinct origin from the cell of the hematopoietic malignant clone.

摘要

最近在体外鉴定出两种假定类型的循环内皮祖细胞

(1)内皮集落形成细胞(ECFC)和(2)内皮细胞集落形成单位(CFU-EC)。目前仅前者被认为属于内皮谱系。我们使用ECFC和CFU-EC检测方法,重新探讨费城染色体阳性和费城染色体阴性慢性骨髓增殖性疾病患者中内皮祖细胞与造血干细胞之间的克隆关系问题。从外周血单个核细胞中培养出ECFC和CFU-EC,并在这两种类型的内皮集落中评估BCR-ABL重排或JAK2-V617F突变。我们发现ECFC缺乏疾病特异性标志物,而这些标志物在CFU-EC中存在,从而强化了后者属于造血谱系的概念,并表明在慢性骨髓增殖性疾病中,产生循环ECFC的细胞与造血恶性克隆细胞具有不同的起源。

相似文献

1
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker.慢性骨髓增殖性疾病患者的内皮祖细胞缺乏疾病特异性分子克隆性标志物。
Blood. 2009 Oct 1;114(14):3127-30. doi: 10.1182/blood-2008-12-190991. Epub 2009 Jul 23.
2
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms.内皮祖细胞是克隆性的,在一部分 Ph 阴性骨髓增生性肿瘤伴血栓形成的患者中存在 JAK2(V617F)突变。
Blood. 2011 Mar 3;117(9):2700-7. doi: 10.1182/blood-2010-07-297598. Epub 2011 Jan 6.
3
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals.通过克隆分析和造血干细胞/祖细胞原理重新定义内皮祖细胞。
Blood. 2007 Mar 1;109(5):1801-9. doi: 10.1182/blood-2006-08-043471. Epub 2006 Oct 19.
4
Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases.骨髓增殖性疾病患者造血及内皮祖细胞的迁移
Haematologica. 2006 Nov;91(11):1465-72.
5
JAK2-mutant vascular niche contributes to JAK2 clonal expansion in myeloproliferative neoplasms.JAK2 突变的血管微环境促进骨髓增殖性肿瘤中 JAK2 的克隆性扩增。
Blood Cells Mol Dis. 2016 Nov;62:42-48. doi: 10.1016/j.bcmd.2016.09.004. Epub 2016 Nov 4.
6
Concomitant BCR-ABL1 translocation and JAK2(V617F) mutation in three patients with myeloproliferative neoplasms.三例骨髓增殖性肿瘤患者中同时存在BCR-ABL1易位和JAK2(V617F)突变
Diagn Mol Pathol. 2012 Sep;21(3):176-83. doi: 10.1097/PDM.0b013e318246975e.
7
Simultaneous occurrence of the JAK2V617F mutation and BCR-ABL gene rearrangement in patients with chronic myeloproliferative disorders.慢性骨髓增殖性疾病患者中JAK2V617F突变与BCR-ABL基因重排的同时发生。
Leuk Res. 2008 Jun;32(6):993-5. doi: 10.1016/j.leukres.2007.10.018. Epub 2007 Dec 4.
8
Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation.伴有BCR-ABL融合及JAK2V617F突变的慢性骨髓增殖性疾病
Leukemia. 2008 May;22(5):1059-62. doi: 10.1038/sj.leu.2404993. Epub 2007 Nov 1.
9
BCR-ABL negative myeloproliferative neoplasia: a review of involved molecular mechanisms.BCR-ABL阴性骨髓增殖性肿瘤:相关分子机制综述
Histol Histopathol. 2015 Feb;30(2):151-61. doi: 10.14670/HH-30.151. Epub 2014 Sep 5.
10
Hematopoietic stem cells, progenitor cells and leukemic stem cells in adult myeloproliferative neoplasms.成人骨髓增殖性肿瘤中的造血干细胞、祖细胞和白血病干细胞。
Leuk Lymphoma. 2013 May;54(5):922-33. doi: 10.3109/10428194.2012.734615. Epub 2012 Oct 24.

引用本文的文献

1
JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte-endothelial proadhesive interactions.JAK-STAT 抑制可减少内皮细胞促血栓形成激活和白细胞-内皮细胞的促黏附相互作用。
J Thromb Haemost. 2023 May;21(5):1366-1380. doi: 10.1016/j.jtha.2023.01.027. Epub 2023 Feb 2.
2
Donor cell-derived myelofibrosis relapse after allogeneic stem cell transplantation.异基因干细胞移植后供体细胞来源的骨髓纤维化复发。
Haematologica. 2023 Jan 1;108(1):278-282. doi: 10.3324/haematol.2022.281564.
3
Human Endothelial Colony-Forming Cells.
人内皮细胞集落形成细胞。
Cold Spring Harb Perspect Med. 2022 Dec 1;12(12):a041154. doi: 10.1101/cshperspect.a041154.
4
A Murine Model With JAK2V617F Expression in Both Hematopoietic Cells and Vascular Endothelial Cells Recapitulates the Key Features of Human Myeloproliferative Neoplasm.一种在造血细胞和血管内皮细胞中均表达JAK2V617F的小鼠模型概括了人类骨髓增殖性肿瘤的关键特征。
Front Oncol. 2021 Oct 26;11:753465. doi: 10.3389/fonc.2021.753465. eCollection 2021.
5
The possible role of mutated endothelial cells in myeloproliferative neoplasms.突变内皮细胞在骨髓增殖性肿瘤中的可能作用。
Haematologica. 2021 Nov 1;106(11):2813-2823. doi: 10.3324/haematol.2021.278499.
6
Cell competition between wild-type and JAK2V617F mutant cells in a murine model of a myeloproliferative neoplasm.在一个骨髓增殖性肿瘤的小鼠模型中,野生型和 JAK2V617F 突变型细胞之间的细胞竞争。
Exp Hematol. 2021 Aug;100:52-62. doi: 10.1016/j.exphem.2021.06.003. Epub 2021 Jun 19.
7
JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment.JAK2V617F 突变内皮细胞在混合血管微环境中促进肿瘤性造血。
Blood Cells Mol Dis. 2021 Sep;90:102585. doi: 10.1016/j.bcmd.2021.102585. Epub 2021 May 31.
8
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms.BCR-ABL1 阴性骨髓增殖性肿瘤中心血管事件的发病机制。
Leukemia. 2021 Apr;35(4):935-955. doi: 10.1038/s41375-021-01170-z. Epub 2021 Mar 3.
9
Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm.在骨髓增殖性肿瘤的小鼠模型中,内皮细胞JAK2V617F突变会导致血栓形成、血管病变和心肌病。
J Thromb Haemost. 2020 Dec;18(12):3359-3370. doi: 10.1111/jth.15095. Epub 2020 Oct 5.
10
Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis.伴有JAK2V617F骨髓增殖性肿瘤和内脏静脉血栓形成的患者中不存在JAK2V617F突变的内皮祖细胞
Hemasphere. 2020 May 5;4(3):e364. doi: 10.1097/HS9.0000000000000364. eCollection 2020 Jun.